Specialty code 183500000X · Vallejo, CA
NPI
1497269757
Since 2017
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
975 Sereno Dr
Vallejo, CA, 94589
Phone (707) 651-1488
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$268K
2,356 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Jai Pal prescribed most often to Medicare patients was Atorvastatin Calcium, with 334 prescriptions and refills. In total Jai Pal wrote 2,356 Medicare prescriptions that cost $268K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-23.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 334 | 1,096 | 134 | $3,979 |
| Metformin Hcl Er Metformin Hcl | 163 | 528 | 69 | $1,665 |
| Glipizide Er Glipizide | 151 | 484 | 57 | $5,147 |
| Metformin Hcl Generic | 139 | 462 | 58 | $1,796 |
| Jardiance Empagliflozin | 126 | 408 | 43 | $67K |
| Ozempic Semaglutide | 123 | 130 | 34 | $92K |
| Glipizide Generic | 123 | 410 | 47 | $1,815 |
| Humulin N Insulin Nph Human Isophane | 87 | 261 | 35 | $19K |
| Humulin R Insulin Regular, Human | 80 | 241 | 32 | $16K |
| Losartan Potassium Generic | 79 | 263 | 31 | $982 |
| Lisinopril Generic | 73 | 243 | 34 | $932 |
| Insulin Glargine-Yfgn Generic | 60 | 168 | 39 | $8,433 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 58 | 172 | 26 | $1,526 |
| Escitalopram Oxalate Generic | 47 | 152 | 19 | $749 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 46 | 127 | 15 | $1,123 |
Brand drugs: 547 claims; generic drugs: 1,659 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Jai Pal were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.